✦ LIBER ✦

508 IS HBEAG LOSS ASSOCIATED WITH AN IMPROVED OUTCOME IN HEPATITIS B PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)?

✍ Scribed by S. Fung; M. Buti; E. Gane; N. Afdhal; J. Flaherty; E. Martins; N. Bekele; J. Bornstein; P. Marcellin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

497 FACTORS ASSOCIATED WITH REGRESSION O

✍ N. Afdhal; M. Buti; S. Fung; E. Gane; J. Flaherty; E. Martins; N. Bekele; J. Bor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 92 KB

740 HBSAG KINETICS IN PATIENTS WITH CHRO

✍ P. Marcellin; E.J. Heathcote; M. Buti; Z. Krastev; I. Jacobson; R.A. de Man; G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

P677 HEPATIC STEATOSIS DOES NOT PREDICT

✍ Buti, M.; Washington, M.K.; Gane, E.; Aguilar Schall, R.; Bornstein, J.D.; Subra 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 73 KB

501 CLINICAL, VIROLOGICAL, SEROLOGICAL A

✍ M. Buti; S. Fung; E. Gane; N. Afdhal; J. Flaherty; E. Martins; N. Bekele; J. Bor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 76 KB

20 THREE YEARS OF TENOFOVIR DISOPROXIL F

✍ M. Rizzetto; P. Marcellin; E.J. Heathcote; J. Sorbel; E. Mondou; J. Anderson; F. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

925 SAFETY AND TOLERABILITY OF 96 WEEKS

✍ P. Marcellin; E.J. Heathcote; I. Jacobson; P. Mathurin; E. Gane; P. Buggisch; P. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 161 KB